Dasher Neuroscience’s Phase II Clinical Trial Project Receives MOEA A+ Program Subsidy

Dasher Neuroscience’s Phase II clinical trial project, “YA-101 for the treatment of Multiple System Atrophy,” has been approved for funding under the Ministry of Economic Affairs (MOEA) A+ Enterprise Innovation R&D Program-FastTrack.